CDKN2A and lung cancer: Studies showed that procainamide demethylated and re-expressed the RARβ2 and p16 genes in urinary bladder carcinoma and breast cancer cells (Cancer Research Technology Ltd, 2007) and the WIF-1 gene in lung cancer cells (Procaine et al., 2009).